Most people have now heard of the promise of AI through GPT-4, but we still have not seen many really mature, real-world clinical applications using advanced language models.
Where PhenOM differs is by using AI to translate specific, actionable insights from our highly-enriched datasets into other data environments at scale, while still maintaining a personalized focus. This capability creates a huge potential for impact, from identifying patients with under-diagnosed conditions to enabling personalized assessments of benefit from particular therapies and accelerating clinical trial enrollment.
Joseph Zabinski, PhD
VP, Head of Commercial Strategy & AI